Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
The originally published version of this Article contained an error in Figure 6. In panel b, the top graph (BrdU 21–24d) and the bottom graph (BrdU 28–31d) were inadvertently swapped. This error has now been corrected in both the PDF and HTML versions of the Article.
Main Authors: | James S. Novak, Marshall W. Hogarth, Jessica F. Boehler, Marie Nearing, Maria C. Vila, Raul Heredia, Alyson A. Fiorillo, Aiping Zhang, Yetrib Hathout, Eric P. Hoffman, Jyoti K. Jaiswal, Kanneboyina Nagaraju, Sebahattin Cirak, Terence A. Partridge |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Nature Portfolio
2018-03-01
|
סדרה: | Nature Communications |
גישה מקוונת: | https://doi.org/10.1038/s41467-018-03709-8 |
פריטים דומים
-
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
מאת: James S. Novak, et al.
יצא לאור: (2017-10-01) -
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
מאת: James S. Novak, et al.
יצא לאור: (2018-01-01) -
Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
מאת: Ugur Akpulat, et al.
יצא לאור: (2018-12-01) -
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
מאת: Aiping Zhang, et al.
יצא לאור: (2015-01-01) -
Defining synphenotype groups in Xenopus tropicalis by use of antisense morpholino oligonucleotides.
מאת: Amer Ahmed Rana, et al.
יצא לאור: (2006-11-01)